CytomX Therapeutics
CTMX
CTMX
130 hedge funds and large institutions have $243M invested in CytomX Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 44 increasing their positions, 47 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
23% less capital invested
Capital invested by funds: $315M → $243M (-$71.4M)
Holders
130
Holding in Top 10
–
Calls
$70K
Puts
$4K
Top Buyers
| 1 | +$2.95M | |
| 2 | +$2.56M | |
| 3 | +$1.9M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.76M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.42M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$8.61M | |
| 3 | -$3.11M | |
| 4 |
First Manhattan
New York
|
-$2.04M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.24M |